Generic Injectables Market

Generic Injectables Market (Product Type - Large Molecule Injectables (Biosimilars), Small Molecule Injectables; Container Type - Vials, Ampoules, Premixes, Prefilled Syringes; Injectables Market - Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology; Route of Administration - Intravenous, Intramuscular, Subcutaneous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL42698
  • Published On : Apr 2018
  • No. of Pages : 203
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentations
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2.  Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Generic Injectables Market Analysis and Forecasts, 2015–2025
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis
     4.6. Market Outlook
     4.7. Global Generic Products Market Condition Overview: by Key Countries
     4.8. Biosimilars:  Pipeline Analysis
     4.9. Generic Injectables Market: Mergers & Acquisitions
     4.10. Global Generics: Industry Trends
     4.11. EU and USFDA Approved Biosimilar Products Snapshot
     4.12: Regulatory Framework for Biosimilar Products
     4.13: Top 10 Players in the U.S. Generic Injectables Market: Company Share Analysis and Market Competition Overview Per Product
     4.14. Challenges Faced by Biosimilar Products to be Approved in the U.S. Market

5. Global Generic Injectables Market Analysis and Forecasts, by Product Type,
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast by Product Type, 2015–2025
            5.3.1. Large Molecule Injectables (Biosimilars)
                     5.3.1.1. Monoclonal Antibodies (mAbs)
                     5.3.1.2. Insulin
                     5.3.1.3. Others
            5.3.2. Small Molecule Injectables
     5.4. Market Attractiveness by Product Type

6. Global Generic Injectables Market Analysis and Forecasts, by Container Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast by Container Type, 2015–2025
            6.3.1. Vials
            6.3.2. Premixes
            6.3.3. Prefilled Syringes
            6.3.4. Ampoules
            6.3.5. Other
     6.4. Market Attractiveness by Container Type

7. Global Generic Injectables Market Analysis and Forecasts, by Route of Administration
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast by Application, 2015–2025
            7.3.1. Oncology
            7.3.2. Infectious Diseases
            7.3.3. Cardiology
            7.3.4. Diabetes
            7.3.5. Immunology
            7.3.6. Others
     7.4. Market Attractiveness by Route of Administration

8. Global Generic Injectables Market Analysis and Forecasts, by Route of Administration
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast by Route of Administration, 2015–2025
            8.3.1. Intravenous
            8.3.2. Intramuscular
            8.3.3. Subcutaneous
            8.3.4. Others
     8.4. Market Attractiveness, by Route of Administration

9. Global Generic Injectables Market Analysis and Forecasts, by Region
     9.1. Key Findings
     9.2. Market Value Forecast by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness, by Country/ Sub-region

10. North America Global Generic Injectables Market Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product Type, 2015–2025
            10.2.1. Large Molecule Injectables (Biosimilars)
                     10.2.1.1. Monoclonal Antibodies (mAbs)
                     10.2.1.2. Insulin
                     10.2.1.3. Others
            10.2.2. Small Molecule Injectables
     10.3. Market Value Forecast, by Container Type, 2015–2025
            10.3.1. Vials
            10.3.2. Premixes
            10.3.3. Prefilled Syringes
            10.3.4. Ampoules
            10.3.5. Others
     10.4. Market Value Forecast, by Application, 2015–2025
            10.4.1. Oncology
            10.4.2. Infectious Diseases
            10.4.3. Cardiology
            10.4.4. Diabetes
            10.4.5. Immunology
            10.4.6. Others
     10.5. Market Value Forecast, by Route of Administration, 2015–2025
            10.5.1. Intravenous
            10.5.2. Intramuscular
            10.5.3. Subcutaneous
            10.5.4. Others
     10.6. Market Value Forecast, by Country, 2015–2025
            10.6.1. U.S.
            10.6.2. Canada
     10.7. Market Attractiveness Analysis
            10.7.1. By Product Type
            10.7.2. By Container Type
            10.7.3. By Route of Administration
            10.7.4. By Route of Administration
            10.7.5. By Country

11. Europe Global Generic Injectables Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product Type, 2015–2025
            11.2.1. Large Molecule Injectables (Biosimilars)
                     11.2.1.1. Monoclonal Antibodies (mAbs)
                     11.2.1.2. Insulin
                     11.2.1.3. Others
            11.2.2. Small Molecule Injectables
     11.3. Market Value Forecast, by Container Type, 2015–2025
            11.3.1. Vials
            11.3.2. Premixes
            11.3.3. Prefilled Syringes
            11.3.4. Ampoules
            11.3.5. Other
     11.4. Market Value Forecast, by Application, 2015–2025
            11.4.1. Oncology
            11.4.2. Infectious Diseases
            11.4.3. Cardiology
            11.4.4. Diabetes
            11.4.5. Immunology
            11.4.6. Others
     11.5. Market Value Forecast, by Route of Administration, 2015–2025
            11.5.1. Intravenous
            11.5.2. Intramuscular
            11.5.3. Subcutaneous
            11.5.4. Others
     11.6. Market Value Forecast, by Country, 2015–2025
            11.6.1. Germany
            11.6.2. U.K.
            11.6.3. France
            11.6.4. Spain
            11.6.5. Italy
            11.6.6. Russia
            11.6.7. Rest of Europe
     11.7. Market Attractiveness Analysis
            11.7.1. By Product Type
            11.7.2. By Container Type
            11.7.3. By Application
            11.7.4. By Route of Administration
            11.7.5. By Country

12. Asia Pacific Global Generic Injectables Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product Type, 2015–2025
            12.2.1. Large Molecule Injectables (Biosimilars)
                     12.2.1.1. Monoclonal Antibodies (mAbs)
                     12.2.1.2. Insulin
                     12.2.1.3. Others
            12.2.2. Small Molecule Injectables
     12.3. Market Value Forecast, by Container Type, 2015–2025
            12.3.1. Vials
            12.3.2. Premixes
            12.3.3. Prefilled Syringes
            12.3.4. Ampoules
            12.3.5. Other
     12.4. Market Value Forecast, by Application, 2015–2025
            12.4.1. Oncology
            12.4.2. Infectious Diseases
            12.4.3. Cardiology
            12.4.4. Diabetes
            12.4.5. Immunology
            12.4.6. Others
     12.5. Market Value Forecast, by Route of Administration, 2015–2025
            12.5.1. Intravenous
            12.5.2. Intramuscular
            12.5.3. Subcutaneous
            12.5.4. Others
     12.6. Market Value Forecast, by Country, 2015–2025
            12.6.1. China
            12.6.2. Japan
            12.6.3. India
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific
     12.7. Market Attractiveness Analysis
            12.7.1. By Product Type
            12.7.2. By Container Type
            12.7.3. By Route of Administration
            12.7.4. By Route of Administration
            12.7.5. By Country

13. Latin America Global Generic Injectables Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast, by Product Type, 2015–2025
            13.2.1. Large Molecule Injectables (Biosimilars)
                     13.2.1.1. Monoclonal Antibodies (mAbs)
                     13.2.1.2. Insulin
                     13.2.1.3. Others
            13.2.2. Small Molecule Injectables
     13.3. Market Value Forecast, by Container Type, 2015–2025
            13.3.1. Vials
            13.3.2. Premixes
            13.3.3. Prefilled Syringes
            13.3.4. Ampoules
            13.3.5. Others
     13.4. Market Value Forecast, by Application, 2015–2025
            13.4.1. Oncology
            13.4.2. Infectious Diseases
            13.4.3. Cardiology
            13.4.4. Diabetes
            13.4.5. Immunology
            13.4.6. Others
     13.5. Market Value Forecast, by Route of Administration, 2015–2025
            13.5.1. Intravenous
            13.5.2. Intramuscular
            13.5.3. Subcutaneous
            13.5.4. Others
     13.6. Market Value Forecast, by Country, 2015–2025
            13.6.1. Brazil
            13.6.2. Mexico
            13.6.3. Rest of Latin America
     13.7. Market Attractiveness Analysis
            13.7.1. By Product Type
            13.7.2. By Container Type
            13.7.3. By Route of Administration
            13.7.4. By Route of Administration
            13.7.5. By Country

14. Middle East & Africa Global Generic Injectables Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2. Market Value Forecast, by Product Type, 2015–2025
            14.2.1. Large Molecule Injectables (Biosimilars)
                     14.2.1.1. Monoclonal Antibodies (mAbs)
                     14.2.1.2. Insulin
                     14.2.1.3. Others
            14.2.2. Small Molecule Injectables
     14.3. Market Value Forecast, by Container Type, 2015–2025
            14.3.1. Vials
            14.3.2. Premixes
            14.3.3. Prefilled Syringes
            14.3.4. Ampoules
            14.3.5. Other
     14.4. Market Value Forecast, by Application, 2015–2025
            14.4.1. Oncology
            14.4.2. Infectious Diseases
            14.4.3. Cardiology
            14.4.4. Diabetes
            14.4.5. Immunology
            14.4.6. Others
     14.5. Market Value Forecast, by Route of Administration, 2015–2025
            14.5.1. Intravenous
            14.5.2. Intramuscular
            14.5.3. Subcutaneous
            14.5.4. Others
     14.6. Market Value Forecast, by Country, 2015–2025
            14.6.1. GCC Countries
            14.6.2. Israel
            14.6.3. South Africa
            14.6.4. Rest of Middle East & Africa
     14.7. Market Attractiveness Analysis
            14.7.1. By Product Type
            14.7.2. By Container Type
            14.7.3. By Route of Administration
            14.7.4. By Route of Administration
            14.7.5. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (by Tier and Size of Companies)
     15.2. Market Share Analysis by Company (2016)
     15.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            15.3.1. Pfizer Inc.
                     15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.1.2 Financial Overview
                     15.3.1.3 Product Portfolio
                     15.3.1.4 SWOT Analysis
                     15.3.1.5 Strategic Overview
            15.3.2. Novartis AG (Sandoz International GmbH)
                     15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.2.2 Financial Overview
                     15.3.2.3 Product Portfolio
                     15.3.2.4 SWOT Analysis
            15.3.3. Baxter
                     15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.3.2 Financial Overview
                     15.3.3.3 Product Portfolio
                     15.3.3.4 SWOT Analysis
                     15.3.3.5 Strategic Overview
            15.3.4. Fresenius SE & Co. KGaA
                     15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.4.2 Financial Overview
                     15.3.4.3 Product Portfolio
                     15.3.4.4 SWOT Analysis
                     15.3.4.5 Strategic Overview
            15.3.5. Mylan N.V.
                     15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.5.2 Financial Overview
                     15.3.5.3 Product Portfolio
                     15.3.5.4 SWOT Analysis
                     15.3.5.5 Strategic Overview
            15.3.6. Teva Pharmaceutical Industries Ltd.
                     15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.6.2 Financial Overview
                     15.3.6.3 Product Portfolio
                     15.3.6.4 SWOT Analysis
                     15.3.6.5 Strategic Overview
            15.3.7. Hikma Pharmaceuticals PLC.
                     15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.7.2 Financial Overview
                     15.3.7.3 Product Portfolio
                     15.3.7.4 SWOT Analysis
                     15.3.7.5 Strategic Overview
            15.3.8. Lupin Ltd.
                     15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.8.2 Financial Overview
                     15.3.8.3 Product Portfolio
                     15.3.8.4 SWOT Analysis
                     15.3.8.5 Strategic Overview
            15.3.9. Sanofi
                     15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.9.2 Financial Overview
                     15.3.9.3 Product Portfolio
                     15.3.9.4 SWOT Analysis
                     15.3.9.5 Strategic Overview
            15.3.10. Biocon
                     15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     15.3.10.2 Financial Overview
                     15.3.10.3 Product Portfolio
                     15.3.10.4 SWOT Analysis
                     15.3.10.5 Strategic Overview

List of Tables

Table 01 Global Generic Injectables Market  Size Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02 Global Generic Injectables Market  Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 03 Global Generic Injectables Market  Size Value (US$ Mn) Forecast, by Application, 2015–2025
Table 04 Global Generic Injectables Market  Size (US$ Mn) Forecast, by Application, 2015–2025
Table 05 Global Generic Injectables Market  Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 06 Global Generic Injectables Market  Size Value (US$ Mn) Forecast, by Region, 2015–2025
Table 07 North America Generic Injectables Market  Size (US$ Mn) Forecast, by Country, 2015–2025
Table 08 North America Generic Injectables Market  Size Value (US$ Mn) Forecast, by  Product Type, 2015–2025
Table 09 North America Generic Injectables Market  Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 10 North America Generic Injectables Market  Size Value (US$ Mn) Forecast, by Container Type, 2015–2025
Table 11 North America Generic Injectables Market  Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12 North America l Generic Injectables Market  Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 13 Europe Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 15 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 16 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015–2025
Table 17 Europe Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 18 Europe l Generic Injectables Market Size (US$ Mn) Forecast, by Route of  Administration, 2015–2025
Table 19 Asia Pacific Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 20 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 21 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 22 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015–2025
Table 23 Asia Pacific Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 24 Asia Pacific l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 25 Latin America Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 27 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 28 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015–2025
Table 29 Latin America Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 30 Latin America l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 31 Middle East & Africa Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 32 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 33 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015–2025
Table 34 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015–2025
Table 35 Middle East & Africa Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 36 Middle East & Africa l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015–202

List of Figures

Figure  01 Global Generic Injectables Market  Snapshot
Figure 02 Global Generic Injectables Market  Size Value (US$ Mn) Forecast, 2015–2025
Figure 03 Market Value Share (%), by Product Type (2016)
Figure 04 Market Value Share (%), by Container Type (2016)
Figure 05 Market Value Share (%), by Route Of Administration (2016)
Figure 06 Market Value Share (%), by Application (2016 )
Figure 07 Global Generic Injectables Market  Value Share Analysis (%), by Product Type, 2017 and 2025
Figure 08 Global Generic Injectables Market  Attractiveness Analysis, by Product Type, 2017–2025
Figure 09 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Large Molecule Injectables, 2015–2025
Figure 10 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Small Molecule Injectables, 2015–2025
Figure 11 Global Generic Injectables Market  Value Share (%), by Container Type, 2017 and 2025
Figure 12 Global Generic Injectables Market  Attractiveness, by Container Type, 2017–2025
Figure 13 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vials, 2015–2025
Figure 14 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ampoules, 2015–2025
Figure 15 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Premixes, 2015–2025
Figure 16 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Prefilled Syringes, 2015–2025
Figure 17 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
Figure 18 Global Generic Injectables Market  Value Share (%), by Application, 2017 and 2025
Figure 19 Global Generic Injectables Market  Attractiveness, by Application, 2017–2025
Figure 20 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diabetes, 2017–2025
Figure 21 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Diseases, 2017–2025
Figure 22 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2017–2025
Figure 23 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diabetes, 2017–2025
Figure 24 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Immunology, 2017–2025
Figure 25 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2025
Figure 26 Global Generic Injectables Market  Value Share (%), by Route of Administration, 2017 and 2025
Figure 27 Global Generic Injectables Market  Attractiveness, by Route of Administration, 2017–2025
Figure 28 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2017–2025
Figure 29 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2017–2025
Figure 30 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2017–2025
Figure 31 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2025
Figure 32 Global Generic Injectables Market  Value Share (%), by Region, 2017 and 2025
Figure 33 Global Generic Injectables Market  Attractiveness, by Region, 2017–2025
Figure 34 North America Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 35 North America Generic Injectables Market  Value Share Analysis, by Country, 2016 and 2025
Figure 36 North America Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
Figure 37 North America Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
Figure 38 North America Generic Injectables Market Attractiveness, by Product Type, 2017–2025
Figure 39 North America Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
Figure 40 North America Generic Injectables Market Attractiveness, by Container Type, 2017–2025
Figure 41 North America Generic Injectables Market Value Share (%), by Application, 2017 and 2025
Figure 42 North America Generic Injectables Market Attractiveness, by Application, 2017–2025
Figure 43 North America Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
Figure 44 North America Generic Injectables Market Attractiveness, by Route of Administration, 2017–2025
Figure 45 Europe Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 46 Europe Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
Figure 47 Europe Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
Figure 48 Europe Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
Figure 49 Europe Generic Injectables Market Attractiveness, by Product Type, 2017–2025
Figure 50 Europe Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
Figure 51 Europe Generic Injectables Market Attractiveness, by Container Type, 2017–2025
Figure 52 Europe Generic Injectables Market Value Share (%), by Application, 2017 and 2025
Figure 53 Europe Generic Injectables Market Attractiveness, by Application, 2017–2025
Figure 54 Europe Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
Figure 55 Europe Generic Injectables Market Attractiveness, by Route of Administration, 2017–2025
Figure 56 Asia Pacific Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 57 Asia Pacific Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
Figure 58 Asia Pacific Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
Figure 59 Asia Pacific Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
Figure 60 Asia Pacific Generic Injectables Market Attractiveness, by Product Type, 2017–2025
Figure 61 Asia Pacific Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
Figure 62 Asia Pacific Generic Injectables Market Attractiveness, by Container Type, 2017–2025
Figure 63 Asia Pacific Generic Injectables Market Value Share (%), by Application, 2017 and 2025
Figure 64 Asia Pacific Generic Injectables Market Attractiveness, by Application, 2017–2025
Figure 65 Asia Pacific Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
Figure 66 Asia Pacific Generic Injectables Market Attractiveness, by Route of Administration, 2017–2025
Figure 67 Latin America Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 68 Latin America Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
Figure 69 Latin America Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
Figure 70 Latin America Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
Figure 71 Latin America Generic Injectables Market Attractiveness, by Product Type, 2017–2025
Figure 72 Latin America Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
Figure 73 Latin America Generic Injectables Market Attractiveness, by Container Type, 2017–2025
Figure 74 Latin America Generic Injectables Market Value Share (%), by Application, 2017 and 2025
Figure 75 Latin America Generic Injectables Market Attractiveness, by Application, 2017–2025
Figure 76 Latin America Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
Figure 77 Latin America Generic Injectables Market Attractiveness, by Route of Administration, 2017–2025
Figure 78 Middle East & Africa Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 79 Middle East & Africa Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
Figure 80 Middle East & Africa Generic Injectables Market Attractiveness Analysis, by Country, 2017-2025
Figure 81 Middle East & Africa Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
Figure 82 Middle East & Africa Generic Injectables Market Attractiveness, by Product Type, 2017–2025
Figure 83 Middle East & Africa Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
Figure 84 Middle East & Africa Generic Injectables Market Attractiveness, by Container Type, 2017–2025
Figure 85 Middle East & Africa Generic Injectables Market Value Share (%), by Application, 2017 and 2025
Figure 86 Middle East & Africa Generic Injectables Market Attractiveness, by Application, 2017–2025
Figure 87 Middle East & Africa Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
Figure 88 Middle East & Africa Generic Injectables Market Attractiveness, by Route of Administration, 2017–2025

.